You are here

Home › Listings › Life Sciences › Medipure Holdings Inc.

Medipure Holdings Inc.

Medipure Holdings Inc.
Listing Exchange: 
CSE
Status: 
Delisted
Industry: 
Life Sciences
Symbol: 
MDH
CSE Index: 
Currency: 

Medipure is developing an extensive network of strategic partnerships with extensive experience in developing cannabinoids, medicines containing controlled substances, as well as plant-based prescription pharmaceutical products. Medipure will attempt to bring novel prescription medicines to market, providing patients with serious conditions valuable solutions that make a real difference to quality of life.

You are here

Home

Medipure Holdings Inc. (MDH)

SEDAR Information

Search form

Company Info

Address
999 Canada Place, Suite 404
Vancouver, BC V6C 3E2
Canada
Phone
604-202-3601
Email
boris@eaglesledge.com
Listing date
Monday, November 10, 2014
Investor Relations
Boris Weiss
Auditor
Davidson & Company LLP

Capitalization

Issued & Outstanding: 
8708655
Reserved for Issuance: 
500

News Releases

17/11/2015

Medipure Announces Resignation of CFO

02/09/2015

Press Release - Closing Private Placement

Bulletins

16/08/2016

2016-0817 - Delist - Medipure Holdings Inc. (MDH)

August 16, 2016

The common shares of Medipure Holdings Inc. will be delisted at the market close today, August  16, 2016. 

Medipure Holdings is currently suspended. 

Date: Market close, August 16, 2016
Symbol: MDH

If you have any questions or require further information, or to be removed from the mailing list please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com 

CSE Filings

Form 7 Monthly Progress Report - July 2016

Monthly Progress Report - June 2016

Monthly Progress Report - May 2016

Monthly Progress Report - April 2016

Form 7 - Monthly Progress Report - March 2016